Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Accurately Document Administration of Controlled Substances

Meyersdale, Pennsylvania Survey Completed on 07-02-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to maintain a complete and accurate accounting of controlled medications for one resident. According to facility policy, staff are required to initial the Medication Administration Record (MAR) after administering each medication and before giving the next, and to maintain an individual controlled substance record for each resident receiving such medications. For one resident with a diagnosis including lumbosacral disc displacement and an order for Dilaudid 2 mg every six hours as needed for severe pain, the controlled drug record showed that doses of Dilaudid were signed out on three separate occasions. However, there was no documented evidence in the resident's MAR that these doses were actually administered on the dates in question. This discrepancy was confirmed by the Director of Nursing, who acknowledged the lack of documentation to indicate that the resident received the signed-out doses. The findings indicate a failure to follow facility policy and regulatory requirements for the administration and documentation of controlled substances.

An unhandled error has occurred. Reload 🗙